1. Home
  2. ATYR vs CRNT Comparison

ATYR vs CRNT Comparison

Compare ATYR & CRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

N/A

Current Price

$0.30

Market Cap

49.2M

Sector

Health Care

ML Signal

N/A

Logo Ceragon Networks Ltd.

CRNT

Ceragon Networks Ltd.

N/A

Current Price

$2.07

Market Cap

213.6M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ATYR
CRNT
Founded
2005
1996
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
49.2M
213.6M
IPO Year
2015
2000

Fundamental Metrics

Financial Performance
Metric
ATYR
CRNT
Price
$0.30
$2.07
Analyst Decision
Hold
Strong Buy
Analyst Count
9
2
Target Price
★ $3.67
$3.50
AVG Volume (30 Days)
★ 2.5M
291.6K
Earning Date
05-01-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 6.98
N/A
EPS
N/A
★ N/A
Revenue
★ $190,000.00
N/A
Revenue This Year
N/A
$9.11
Revenue Next Year
N/A
$6.70
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.28
$1.85
52 Week High
$1.12
$3.29

Technical Indicators

Market Signals
Indicator
ATYR
CRNT
Relative Strength Index (RSI) 27.82 44.77
Support Level N/A $2.03
Resistance Level $0.59 $2.14
Average True Range (ATR) 0.03 0.06
MACD -0.01 0.01
Stochastic Oscillator 16.37 29.55

Price Performance

Historical Comparison
ATYR
CRNT

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

About CRNT Ceragon Networks Ltd.

Ceragon Networks Ltd is a wireless transport specialist, providing wireless connectivity solutions to markets globally across various industries, including wireless (mobile) network service providers and private networks, enabling them to build new networks and evolve networks towards 4G and 5G services. Its portfolio mainly comprises the IP-20 and IP-50 product series, including integrated multi-technology radio units operating across frequencies from 4 GHz to 86 GHz, as well as single-radio devices used for wireless data transport. Additionally, the company offers turnkey services including: network and radio planning, site survey, installation, network auditing and optimization, and more. Geographically, it derives maximum revenue from India, followed by North America and other regions.

Share on Social Networks: